DexCom, Inc. (LON:0A4M)

Market Cap	27.44B
Revenue (ttm)	3.22B
Net Income (ttm)	460.25M
Shares Out	n/a
EPS (ttm)	1.14
PE Ratio	59.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,303
Average Volume	4,567
Open	90.77
Previous Close	n/a
Day's Range	90.77 - 90.77
52-Week Range	49.56 - 112.76
Beta	n/a
RSI	70.82
Earnings Date	Feb 6, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into t...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 9,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD